Additionally, it is described that this hybrid immunity also showed higher serological protection in the respiratory tract, the main infection route of SARS-CoV-2, especially due to elevated levels of IgA antibody response in the mucosa after vaccination (48, 49). The gene discussed is CD79A; the disease is infection.